135 related articles for article (PubMed ID: 25442323)
1. Inhibition of microbial β-N-acetylhexosaminidases by 4-deoxy- and galacto-analogues of NAG-thiazoline.
Krejzová J; Kalachova L; Šimon P; Pelantová H; Slámová K; Křen V
Bioorg Med Chem Lett; 2014 Nov; 24(22):5321-3. PubMed ID: 25442323
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of GlcNAc-processing glycosidases by C-6-azido-NAG-thiazoline and its derivatives.
Krejzová J; Simon P; Kalachova L; Kulik N; Bojarová P; Marhol P; Pelantová H; Cvačka J; Ettrich R; Slámová K; Křen V
Molecules; 2014 Mar; 19(3):3471-88. PubMed ID: 24658571
[TBL] [Abstract][Full Text] [Related]
3. Analysis of PUGNAc and NAG-thiazoline as transition state analogues for human O-GlcNAcase: mechanistic and structural insights into inhibitor selectivity and transition state poise.
Whitworth GE; Macauley MS; Stubbs KA; Dennis RJ; Taylor EJ; Davies GJ; Greig IR; Vocadlo DJ
J Am Chem Soc; 2007 Jan; 129(3):635-44. PubMed ID: 17227027
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of NAG-thiazoline-derived inhibitors for β-N-acetyl-d-hexosaminidases.
Kong H; Chen W; Lu H; Yang Q; Dong Y; Wang D; Zhang J
Carbohydr Res; 2015 Sep; 413():135-44. PubMed ID: 26142545
[TBL] [Abstract][Full Text] [Related]
5. Computational analysis of human OGA structure in complex with PUGNAc and NAG-thiazoline derivatives.
de Alencar NA; Sousa PR; Silva JR; Lameira J; Alves CN; Martí S; Moliner V
J Chem Inf Model; 2012 Oct; 52(10):2775-83. PubMed ID: 22937904
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of NAM-thiazoline derivatives as novel O-GlcNAcase inhibitors.
Kong H; Chen W; Liu T; Lu H; Yang Q; Dong Y; Liang X; Jin S; Zhang J
Carbohydr Res; 2016 Jun; 429():54-61. PubMed ID: 27233493
[TBL] [Abstract][Full Text] [Related]
7. A quantum mechanics/molecular mechanics study of the protein-ligand interaction of two potent inhibitors of human O-GlcNAcase: PUGNAc and NAG-thiazoline.
Lameira J; Alves CN; Moliner V; Martí S; Kanaan N; Tuñón I
J Phys Chem B; 2008 Nov; 112(45):14260-6. PubMed ID: 18939790
[TBL] [Abstract][Full Text] [Related]
8. Identification of a specific inhibitor of nOGA - a caspase-3 cleaved O-GlcNAcase variant during apoptosis.
Li J; Li Z; Li T; Lin L; Zhang Y; Guo L; Xu Y; Zhao W; Wang P
Biochemistry (Mosc); 2012 Feb; 77(2):194-200. PubMed ID: 22348480
[TBL] [Abstract][Full Text] [Related]
9. Expression of human β-N-acetylhexosaminidase B in yeast eases the search for selective inhibitors.
Krejzová J; Kulik N; Slámová K; Křen V
Enzyme Microb Technol; 2016 Jul; 89():1-6. PubMed ID: 27233122
[TBL] [Abstract][Full Text] [Related]
10. O-GlcNAcase uses substrate-assisted catalysis: kinetic analysis and development of highly selective mechanism-inspired inhibitors.
Macauley MS; Whitworth GE; Debowski AW; Chin D; Vocadlo DJ
J Biol Chem; 2005 Jul; 280(27):25313-22. PubMed ID: 15795231
[TBL] [Abstract][Full Text] [Related]
11. NAG-thiazoline is a potent inhibitor of the Vibrio campbellii GH20 β-N-Acetylglucosaminidase.
Meekrathok P; Stubbs KA; Aunkham A; Kaewmaneewat A; Kardkuntod A; Bulmer DM; van den Berg B; Suginta W
FEBS J; 2020 Nov; 287(22):4982-4995. PubMed ID: 32145141
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of O-GlcNAcase in perfused rat hearts by NAG-thiazolines at the time of reperfusion is cardioprotective in an O-GlcNAc-dependent manner.
Laczy B; Marsh SA; Brocks CA; Wittmann I; Chatham JC
Am J Physiol Heart Circ Physiol; 2010 Nov; 299(5):H1715-27. PubMed ID: 20833964
[TBL] [Abstract][Full Text] [Related]
13. Exploring NAG-thiazoline and its derivatives as inhibitors of chitinolytic β-acetylglucosaminidases.
Liu T; Xia M; Zhang H; Zhou H; Wang J; Shen X; Yang Q
FEBS Lett; 2015 Jan; 589(1):110-6. PubMed ID: 25436416
[TBL] [Abstract][Full Text] [Related]
14. Insight into a strategy for attenuating AmpC-mediated beta-lactam resistance: structural basis for selective inhibition of the glycoside hydrolase NagZ.
Balcewich MD; Stubbs KA; He Y; James TW; Davies GJ; Vocadlo DJ; Mark BL
Protein Sci; 2009 Jul; 18(7):1541-51. PubMed ID: 19499593
[TBL] [Abstract][Full Text] [Related]
15. Selective inhibition of β-N-acetylhexosaminidases by thioglycosyl-naphthalimide hybrid molecules.
Chen W; Shen S; Dong L; Zhang J; Yang Q
Bioorg Med Chem; 2018 Jan; 26(2):394-400. PubMed ID: 29242020
[TBL] [Abstract][Full Text] [Related]
16. Structural basis for the substrate specificity of a novel β-N-acetylhexosaminidase StrH protein from Streptococcus pneumoniae R6.
Jiang YL; Yu WL; Zhang JW; Frolet C; Di Guilmi AM; Zhou CZ; Vernet T; Chen Y
J Biol Chem; 2011 Dec; 286(50):43004-12. PubMed ID: 22013074
[TBL] [Abstract][Full Text] [Related]
17. 4-Deoxy-substrates for beta-N-acetylhexosaminidases: how to make use of their loose specificity.
Slámová K; Gazák R; Bojarová P; Kulik N; Ettrich R; Pelantová H; Sedmera P; Kren V
Glycobiology; 2010 Aug; 20(8):1002-9. PubMed ID: 20466648
[TBL] [Abstract][Full Text] [Related]
18. N-Acetylhexosaminidase inhibitory properties of C-1 homologated GlcNAc- and GalNAc-thiazolines.
Amorelli B; Yang C; Rempel B; Withers SG; Knapp S
Bioorg Med Chem Lett; 2008 May; 18(9):2944-7. PubMed ID: 18406613
[TBL] [Abstract][Full Text] [Related]
19. Age dependence of serum beta-N-acetylhexosaminidase (NAG) activity.
Oláh AV; Price RG; Csáthy L; Országh E; Oláh E; Varga J
Clin Chem Lab Med; 2004 Mar; 42(3):305-6. PubMed ID: 15080564
[TBL] [Abstract][Full Text] [Related]
20. Enzyme molecular mechanism as a starting point to design new inhibitors: a theoretical study of O-GlcNAcase.
Lameira J; Alves CN; Tuñón I; Martí S; Moliner V
J Phys Chem B; 2011 May; 115(20):6764-75. PubMed ID: 21542586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
